Nicole F. Bernard, PhD

Primary Axis: 
Infection and Immunity
Research Focus: 

My research focus is the study of the immune correlates of protection against HIV infection in a subset of individuals who remain uninfected despite multiple exposures to this virus. The research program is based on the hypothesis that NK cells play a role in protection from HIV infection. NK cells, as key players in innate immunity, can mediate antiviral functions early after exposure to HIV infected cells and possibly prevent the establishment of a progressive infection. NK anti-viral function is determined by a process called licensing that is dependent of the integration of signals from cell surface activating and inhibitory receptors that sense the presence of ligands on other cells. I am interested in the link between carriage of NK receptor –ligand pairs that are associated with HIV protection and the antiviral functional potential of NK cells from these individuals. We also study correlates of immune protection against disease progression in infected subjects who progress slowly as defined by spontaneously controlling viral load or maintaining high CD4 counts long term.

Keywords: 
HIV/AIDS, HIV resistance, NK cells, HLA, Killer Immunoglobulin-like Receptors, CD8+ T cells, Cytokine Secretion, Cytolysis, Long Term Non Progressors, Elite Controllers
Location: 
Montreal General Hospital
Publications:
Boulet, S, R Song, P Kamya, J Bruneau, , NH Shoukry, CM Tsoukas and NF Bernard. HIV protective KIR4DL1-HLA-B combined genotypes influence natural killer cell function following stimulation with HLA-devoid cells. J Immunol 184:2057-64, 2010
Boulet S and NF Bernard. Protection contre le VIH: Une synergie entre KIR3DL1 et HLA-B*57. Med Sci, 12 :1030-32, 2008
Boulet S, M Kleyman, JY Kim, P Kamya, S Sharafi, N Simic, J Bruneau, J-P Routy, CM Tsoukas, NF Bernard. Increased frequency of KIR3DL1 subtypes with HLA-B57 in exposed uninfected compared with HIV susceptible individuals. AIDS, 22:1487-91, 2008

Articles